Literature DB >> 17125593

Differential proteomic profiling to study the mechanism of cardiac pharmacological preconditioning by resveratrol.

Karel Bezstarosti1, Samarjit Das, Jos M J Lamers, Dipak K Das.   

Abstract

Recent studies demonstrated that resveratrol, a grape-derived polyphenolic phytoalexin, provides pharmacological preconditioning of the heart through a NO-dependent mechanism. To further explore the molecular mechanisms involved in resveratrol-mediated cardioprotection, we monitored the effects of resveratrol treatment after ischemia-reperfusion on the protein profile by implementation of proteomic analysis. Two groups of rats were studied; one group of animals was fed resveratrol for 7 days, while the other group was given vehicle only. The rats were sacrificed for the isolated working heart preparation and for isolation of cytoplasmic fraction from left ventricle homogenates to carry out the proteomic as well as immunoblot at baseline and at the end of 30 min ischemia/2-h perfusion. The results demonstrate significant cardioprotection with resveratrol evidenced by improved ventricular recovery and reduced infarct size and cardiomyocyte apoptosis. The left ventricular cytoplasmic fractions were separated by two-dimensional electrophoresis (2-DE). Differentially regulated proteins were detected with quantitative computer analysis of the Coomassie blue stained 2-DE images and identified by MALDI-TOF (MS) and nanoLC-ESI-Q-TOF mass spectrometry (MS/MS). Five redox-regulated and preconditioning- related proteins were identified that were all upregulated by resveratrol: MAPKK, two different alphaB-crystallin species, HSP 27 and PE binding protein. Another HSP27 species and aldose reductase were downregulated and peroxiredoxin- 2 remained constant. The results of the immunoblot analysis of phosphorylated MAPKK, -HSP27 and -alphaB-crystallin and PE binding protein were consistent with the proteomic findings, but not with peroxiredoxin-2. The proteomic analysis showed also downregulation of some proteins in the mitochondrial respiratory chain and matrix and the myofilament regulating protein MLC kinase-2. The results of the present study demonstrate that proteomic profiling enables the identification of resveratrol induced preconditioning-associated proteins which reflects not only changes in their expression level but also isoforms, post-translational modifications and regulating binding or activating partner proteins.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17125593      PMCID: PMC3933086          DOI: 10.1111/j.1582-4934.2006.tb00533.x

Source DB:  PubMed          Journal:  J Cell Mol Med        ISSN: 1582-1838            Impact factor:   5.310


  32 in total

1.  Proteomic analysis of pharmacologically preconditioned cardiomyocytes reveals novel phosphorylation of myosin light chain 1.

Authors:  D K Arrell; I Neverova; H Fraser; E Marbán; J E Van Eyk
Journal:  Circ Res       Date:  2001-09-14       Impact factor: 17.367

Review 2.  Resveratrol in cardioprotection: a therapeutic promise of alternative medicine.

Authors:  Dipak K Das; Nilanjana Maulik
Journal:  Mol Interv       Date:  2006-02

3.  Coordinated induction of iNOS-VEGF-KDR-eNOS after resveratrol consumption: a potential mechanism for resveratrol preconditioning of the heart.

Authors:  Samarjit Das; Vijay K T Alagappan; Debasis Bagchi; Hari S Sharma; Nilanjana Maulik; Dipak K Das
Journal:  Vascul Pharmacol       Date:  2005 Apr-May       Impact factor: 5.773

4.  Cardioprotective effect of resveratrol, a natural antioxidant derived from grapes.

Authors:  L M Hung; J K Chen; S S Huang; R S Lee; M J Su
Journal:  Cardiovasc Res       Date:  2000-08-18       Impact factor: 10.787

5.  Regulation of cardiomyocyte apoptosis by redox-sensitive transcription factors.

Authors:  N Maulik; H Sasaki; S Addya; D K Das
Journal:  FEBS Lett       Date:  2000-11-17       Impact factor: 4.124

6.  Proteomic changes in the pressure overloaded right ventricle after 6 weeks in young rats: correlations with the degree of hypertrophy.

Authors:  Matthijs J Faber; Michiel Dalinghaus; Inge M Lankhuizen; Karel Bezstarosti; Dick H W Dekkers; Dirk J Duncker; Willem A Helbing; Jos M J Lamers
Journal:  Proteomics       Date:  2005-07       Impact factor: 3.984

7.  Resveratrol-mediated activation of cAMP response element-binding protein through adenosine A3 receptor by Akt-dependent and -independent pathways.

Authors:  Samarjit Das; Arpad Tosaki; Debasis Bagchi; Nilanjana Maulik; Dipak K Das
Journal:  J Pharmacol Exp Ther       Date:  2005-05-05       Impact factor: 4.030

8.  Protein kinase C epsilon signaling complexes include metabolism- and transcription/translation-related proteins: complimentary separation techniques with LC/MS/MS.

Authors:  Ricky D Edmondson; Thomas M Vondriska; Kelli J Biederman; Jun Zhang; Richard C Jones; Yuting Zheng; David L Allen; Joanne X Xiu; Ernest M Cardwell; Michael R Pisano; Peipei Ping
Journal:  Mol Cell Proteomics       Date:  2002-06       Impact factor: 5.911

Review 9.  Proteomics of the heart: unraveling disease.

Authors:  Emma McGregor; Michael J Dunn
Journal:  Circ Res       Date:  2006-02-17       Impact factor: 17.367

10.  A novel human phosphatidylethanolamine-binding protein resists tumor necrosis factor alpha-induced apoptosis by inhibiting mitogen-activated protein kinase pathway activation and phosphatidylethanolamine externalization.

Authors:  Xiaojian Wang; Nan Li; Bin Liu; Hongying Sun; Taoyong Chen; Hongzhe Li; Jianming Qiu; Lihuang Zhang; Tao Wan; Xuetao Cao
Journal:  J Biol Chem       Date:  2004-08-09       Impact factor: 5.157

View more
  7 in total

Review 1.  Proteostasis and REDOX state in the heart.

Authors:  Elisabeth S Christians; Ivor J Benjamin
Journal:  Am J Physiol Heart Circ Physiol       Date:  2011-10-14       Impact factor: 4.733

2.  Proteomic analysis of the serum in patients with idiopathic pulmonary arterial hypertension.

Authors:  Min Yu; Xing-xiang Wang; Fu-rong Zhang; Yun-peng Shang; Yu-xi Du; Hong-juan Chen; Jun-zhu Chen
Journal:  J Zhejiang Univ Sci B       Date:  2007-04       Impact factor: 3.066

3.  Aldose reductase mediates myocardial ischemia-reperfusion injury in part by opening mitochondrial permeability transition pore.

Authors:  Radha Ananthakrishnan; Michiyo Kaneko; Yuying C Hwang; Nosirudeen Quadri; Teodoro Gomez; Qing Li; Casper Caspersen; Ravichandran Ramasamy
Journal:  Am J Physiol Heart Circ Physiol       Date:  2008-12-05       Impact factor: 4.733

4.  Retracted: Differential proteomic profiling to study the mechanism of cardiac pharmacological preconditioning by resveratrol.

Authors: 
Journal:  J Cell Mol Med       Date:  2012-10       Impact factor: 5.310

5.  Identification by a differential proteomic approach of the induced stress and redox proteins by resveratrol in the normal and diabetic rat heart.

Authors:  D H W Dekkers; K Bezstarosti; N Gurusamy; K Luijk; A J M Verhoeven; E-J Rijkers; J A Demmers; J M J Lamers; N Maulik; D K Das
Journal:  J Cell Mol Med       Date:  2008-01-11       Impact factor: 5.310

6.  Co-ordinated autophagy with resveratrol and γ-tocotrienol confers synergetic cardioprotection.

Authors:  Istvan Lekli; Diptarka Ray; Subhendu Mukherjee; Narasimman Gurusamy; Md Kaimul Ahsan; Bela Juhasz; Istvan Bak; Arpad Tosaki; Mihaela Gherghiceanu; Lawrence M Popescu; Dipak K Das
Journal:  J Cell Mol Med       Date:  2010-10       Impact factor: 5.310

Review 7.  Adrenergic signaling and oxidative stress: a role for sirtuins?

Authors:  Graziamaria Corbi; Valeria Conti; Giusy Russomanno; Giancarlo Longobardi; Giuseppe Furgi; Amelia Filippelli; Nicola Ferrara
Journal:  Front Physiol       Date:  2013-11-08       Impact factor: 4.566

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.